Trial intelligence / Profile preview

Esketamine for opioid-free anesthesia and postoperative nausea/vomiting

ChiCTR2100047169Phase 4Recruiting

Sponsor
Shidong Hospital
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shidong Hospital. Primary endpoint: incidence of postoperative nausea and vomiting. Started Aug 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ChiCTR2100047169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call